RM Evans - The Keio Journal of Medicine, 2004 - J-STAGE I would like to thank all of you for staying through this long day of lectures,
as I get to have the last word. I wish to thank Drs. Hayashi and Kizaki for
their kind remarks and for keeping everyone on time and to also thank Dr. ... Cited by 514 - Related articles - BL Direct - All 8 versions
T Rankinen, A Zuberi, YC Chagnon, SJ … - Obesity, 2006 - pbrc.edu Abstract RANKINEN, TUOMO, AAMIR ZUBERI, YVON C. CHAGNON, S. JOHN WEISNAGEL,
GEORGE ARGYROPOULOS, BRANDON WALTS, LOUIS PE´RUSSE, AND CLAUDE BOUCHARD. The
human obesity gene map: the 2005 update. Obesity. 2006;14: 529–644. This ... Cited by 335 - Related articles - View as HTML - All 6 versions
- ►shouxi.net A Garg - The New England journal of medicine, 2004 - nejm.org Lipodystrophies are clinically heterogeneous acquired or inherited disorders
characterized by the selective loss of adipose tissue. Affected patients are
predisposed to insulin resistance and its attendant complications, ... Cited by 251 - Related articles - BL Direct - All 10 versions
- ►cell.com JP Berger, TE Akiyama, PT Meinke - Trends in Pharmacological Sciences, 2005 - Elsevier The three peroxisome-proliferator-activated receptor (PPAR) subtypes, PPAR-γ,
PPAR-α and PPAR-δ, are nuclear receptors that have been the focus of extensive
research during the past decade. These receptors function as lipid sensors ... Cited by 244 - Related articles - All 6 versions
EE Snyder, B Walts, L Pérusse, YC Chagnon, … - update, 2004 - Citeseer WEISNAGEL, TUOMO RANKINEN, AND CLAUDE BOUCHARD. The human obesity gene map: the
2003 update. Obes Res. 2004;12:369–439. This is the tenth update of the human
obesity gene map, incorporating published results up to the end of October ... Cited by 240 - Related articles - View as HTML - BL Direct - All 7 versions
- ►nih.gov RK Semple, VKK Chatterjee, SO'Rahilly - Journal of Clinical Investigation, 2006 - Am Soc Clin Investig The nuclear receptor family of PPARs was named for the ability of the original
member to induce hepatic peroxisome proliferation in mice in response to
xenobiotic stimuli. However, studies on the action and structure of the 3 ... Cited by 243 - Related articles - BL Direct - All 10 versions
L Perusse, T Rankinen, A Zuberi, YC Chagnon … - Obesity research, 2005 - informatik.hu-berlin.de Abstract PE´ RUSSE, LOUIS, TUOMO RANKINEN, AAMIR ZUBERI, YVON C. CHAGNON, S.
JOHN WEISNAGEL, GEORGE ARGYROPOULOS, BRANDON WALTS, ERIC E. SNYDER, AND CLAUDE
BOUCHARD. The human obesity gene map: the 2004 update. Obes Res. 2005; ... Cited by 210 - Related articles - View as HTML - All 6 versions
- ►endojournals.org C Knouff, J Auwerx - Endocrine Reviews, 2004 - Endocrine Soc The peroxisome proliferator-activated receptor (PPAR ) is a prototypical member
of the nuclear receptor superfamily and integrates the control of energy, lipid,
and glucose homeostasis. PPAR can bind a variety of small lipophilic ... Cited by 146 - Related articles - All 5 versions
- ►diabetesjournals.org J Tonelli, W Li, P Kishore, UB Pajvani, E … - Diabetes, 2004 - Am Diabetes Assoc Whereas thiazolidinediones (TZDs) are known to rapidly improve insulin action in
animals, short durations of TZD therapy have never been studied in humans. Among
the many known actions of TZDs, increased circulating levels of the high ... Cited by 143 - Related articles - BL Direct - All 5 versions
J Medina, LI Fernández-Salazar, L García- … - Diabetes care, 2004 - Am Diabetes Assoc Nonalcoholic steatohepatitis (NASH) represents an advanced stage of fatty liver
disease developed in the absence of alcohol abuse. Its increasing prevalence in
western countries, the diagnostic difficulties by noninvasive tests, and ... Cited by 137 - Related articles - All 8 versions
